📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Measuring indirect transmission-reducing effects in tuberculosis vaccine efficacy trials: why and how? (2023)

First Author: Nelson KN

Attributed to: Infection prevention and control for drug-resistant tuberculosis in South Africa in the era of decentralised care: a whole systems approach funded by ESRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s2666-5247(23)00112-x

PubMed Identifier: 37329893

Publication URI: http://europepmc.org/abstract/MED/37329893

Type: Journal Article/Review

Volume: 4

Parent Publication: The Lancet. Microbe

Issue: 8

ISSN: 2666-5247